During the past decade, Monument Health Clinical Research conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monument Health Clinical Research" #1 sponsor was "Amgen" with 3 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "NewAmsterdam Pharma" with 2 trials sponsored, "Abiomed Inc." with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monument Health Clinical Research" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Monument Health Clinical Research" are "Atherosclerotic Cardiovascular Disease" (2 trials), "COVID-19" (2 trials), "Dyslipidemias" (2 trials), "High Cholesterol" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Monument Health Clinical Research" in a lesser frequency.

Most popular intervention types in "Monument Health Clinical Research" are "Drug" (10 trials), "Other" (4 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Obicetrapib" (2 trials), "Remdesivir" (2 trials), "Alogliptin Benzoate" (1 trials) and "Apixaban 2.5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monument Health Clinical Research" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Monument Health Clinical Research". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Monument Health Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Monument Health Clinical Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".